This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Unpack the common reasons budgeting is hard and learn approachable methods to develop healthier financial habits.
24,094 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A prominent market strategist says investors should their money in gold, proposing a 10% allocation to hedge inflatio...
Quantum tech is moving from dream to data. This article explores Rigetti Computing, its revenue path, risks, and a pr...
SoFi has surprised some investors by turning a key profitability metric into a clear strength. This article breaks do...
When a network equipment company taps the market for capital, a stock pullback often follows. Here’s a clear, investo...
As markets navigated a cautious session, Sunrun’s new framework with Tesla and Renew Home pushed renewable energy equ...
This week brought a notable pullback in AI hardware names, including CoreWeave. Read a clear, practical look at what ...
As Rocket Lab nears a pivotal earnings print, investors are quietly growing more bullish. This piece breaks down why ...
Hims Hers Health shares jumped after news of a Novo Nordisk collaboration. This guide breaks down what the deal could...
VR Adviser recently disclosed a substantial sale of Ocular Therapeutix shares, triggering questions about what it mea...
The crypto market kicked off 2026 with volatility, but three tokens jumped 25% or more. Dive into what drove these ga...
A nationwide, specialized model for wealth management is gaining momentum among high-net-worth clients, offering acce...